abstract |
The present invention relates generally to compounds of formula (IA): (IA) n n n the preparation thereof, pharmaceutical formulations thereof, and their use in medicine as potent or selective A 2B adenosine receptor antagonists and their uses for treating asthma, autoimmune diseases and retinal vascular diseases. |